SCHEMBL2484864

SCHEMBL2484864

Cc1cc(OC(=O)c2ccccc2)c(OC(=O)c2ccccc2)c(C2CCCCC2)c1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 2/20 0.46
KMT2A Q03164 6/20 0.43
ALDH1A1 P00352 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
STAT3 P40763 1/20 0.43
MAPT P10636 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MEN1 O00255 2/20 0.39
KMO O15229 1/20 0.39
SLC6A3 Q01959 1/20 0.39
MDM2 Q00987 1/20 0.39
LMNA P02545 1/20 0.38
CYP2D6 P10635 1/20 0.38
SCN1A P35498 1/20 0.38
SCN2A Q99250 1/20 0.38
SCN3A Q9NY46 1/20 0.38
ATM Q13315 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2506366 0.99 PTGDR2 (0.44) PTGDR2KMT2AALDH1A1CYP1A2CYP2C9
SCHEMBL2482272 0.86 KMO (0.46) PTGDR2KMT2AALDH1A1CYP1A2CYP2C9
SCHEMBL2507641 0.86 KMO (0.46) PTGDR2KMT2AALDH1A1CYP1A2CYP2C9
SCHEMBL2484042 0.86 KMO (0.46) PTGDR2KMT2AALDH1A1CYP1A2CYP2C9
SCHEMBL2506534 0.85 KMT2A (0.43) PTGDR2KMT2AALDH1A1CYP1A2CYP2C9
SCHEMBL2484610 0.85 KMT2A (0.43) PTGDR2KMT2AALDH1A1CYP1A2CYP2C9
SCHEMBL2484027 0.85 KMT2A (0.44) PTGDR2KMT2AALDH1A1CYP1A2CYP2C9
SCHEMBL2885886 0.84 MAPT (0.45) PTGDR2KMT2AALDH1A1CYP1A2CYP2C9
SCHEMBL2483330 0.84 CYP1A2 (0.41) PTGDR2KMT2AALDH1A1CYP1A2CYP2C9
SCHEMBL2484451 0.84 KMT2A (0.43) PTGDR2KMT2AALDH1A1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8604235-B2 Production of substituted phenylene aromatic diesters and compositions DOW GLOBAL TECHNOLOGIES LLC (US) 2013-12-10 US disclosed
EP-2376423-A1 PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS Dow Global Technologies LLC (US) 2011-10-19 EP disclosed
US-20100204506-A1 Production of Substituted Phenylene Aromatic Diesters and Compositions W. R. GRACE & CO.-CONN. 2010-08-12 US disclosed
WO-2010078519-A1 PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS DOW GLOBAL TECHNOLOGIES INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204506-A1 Production of Substituted Phenylene Aromatic Diesters and Compositions PAH, DDC, DDT PTGDR2 1971/4885KMT2A 1611/4885ALDH1A1 240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.